Treatment of idiopathic clubfoot utilizing botulinum A toxin: A new method and its short-term outcomes

Journal of Pediatric Orthopaedics

Volumn 25, Issue 2, 2005, Pages 229-235

  Alvarez, Christine M ^a,b   Tredwell, Stephen J ^a   Keenan, Sean P ^a   Beauchamp, Richard D ^a   Choit, Rachel L ^a   Sawatzky, Bonita J ^a   De Vera, Mary A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Botulinum A toxin; Clubfoot

Indexed keywords

BOTULINUM TOXIN A;

ACHILLES TENDON; ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PROTOCOL; CLUBFOOT; CONTROLLED STUDY; HUMAN; JOINT FUNCTION; MAJOR CLINICAL STUDY; PIRANI SCORE; PLASTER CAST; PRIORITY JOURNAL; SCORING SYSTEM; TENOTOMY; TRICEPS SURAE MUSCLE;

BOTULINUM TOXIN TYPE A; CHILD, PRESCHOOL; CLUBFOOT; HUMANS; INFANT; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 14644422290     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bpo.0000149861.50400.db     Document Type: Article

References (49)

1. Alkjaer T, Pedersen EN, Simonsen EB. Evaluation of the walking pattern in clubfoot patients who received early intensive treatment. J Pediatr Orthop. 2000;20:642-647.
2. Applington JP, Riddle CD. Avascular necrosis of the body of the talus after combined medial and lateral release of congenital clubfoot. South Med J. 1976;69:1037-1038.
3. Asperheim MS, Moore N, Carroll NC, et al. Evaluation of residual club-foot deformities using gait analysis. J Pediatr Orthop B. 1995;4:49-54.
4. Atar D, Lehman WB, Grant AD. Complications in clubfoot surgery. Orthop Rev. 1991;20:233-239.
5. Bakheit AM, Severa S, Cosgrove A, et al. Safety profile and efficacy of Botulinum toxin A (Dysport) in children with muscle spasticity. Dev Med Child Neurol. 2001;43:234-238.
6. Bang MS, Chung SG, Kim SB. et al. Change of dynamic gastroenemius and soleus muscle length after block of spastic muscle in cerebral palsy. Am J Phys Med Rehabil. 2002;81:760-764.
7. Bensahel H, Guillaume A, Desgrippes Y. Results of physical therapy for idiopathic clubfoot: a long-term follow-up. J Pediatr Orthop. 1990;10: 189-192.
8. Brin MF, ed. Spasticity: etiology, evaluation, management, and the role of botulinum toxin A. Muscle Nerve. 1997;20(Supp 6):61-91.
9. Carroll NC, McMurtry R, Leete SF. The pathoanatomy of congenital clubfoot. Orthop Clin North Am. 1978;9:225-232.
10. Carroll NC. Surgical technique for talipes equinovarus. Oper Tech Orthop. 1993;3:115-120.
11. Chotel F, Parot R. Durand J, et al. Initial management of congenital varus clubfoot by Ponseti's method. Rev Chir Orthop Reparatrice Appar Mol. 2002;88:710-717.
12. Cooper DM, Dietz FR. Treatment of idiopathic clubfeet: a thirty-year follow-up note. J Bone Joint Surg [Am]. 1995;77:1477-1489.
13. Crawford AH, Marxen JL, Osterfeld DL. The Cincinnati incision; a comprehensive approach for surgical procedures of the foot and ankle in childhood. J Bone Joint Surg [Am]. 1982;64:1355-1358.
14. Crawford AH, Gupta AK. Clubfoot controversies: complications and causes for failure. AAOS Instr Course Led. 1996;45:339-346.
15. rd International Clubfoot Congress, San Diego. California, August 2002.
16. Eames NW, Baker R, Hill N, et al. The effect of botulinum A toxin on gastrocnemius length: magnitude and duration of effect. Dev Med Child Neurol. 1999;41:226-232.
17. Edgar TS. Clinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review. J Child Neurol. 2001;16:37-46.
18. rd International Clubfoot Congress, San Diego, California, August 2002.
19. Goksan SB. Treatment of congenital clubfoot with the Ponseti method. Acta Orthop Traumatol Turc. 2002;36:281-287.
20. Hee HT, Lee EH, Lee GS. Gait and pedographic patterns of surgically treated clubfeet. J Foot Ankle Surg. 2001;40:287-294.
21. Herzenberg JE, Radler CR, Bor N. Ponseti versus traditional methods of casting for idiopathic clubfeet. J Pediatr Orthop. 2002;22:517-521.
22. Juzans P, Comella JX, Molgo J, et al. Nerve terminal sprouting in botulinum A-treated mouse levator auris longus muscle. Neuromuscul Disord. 1996;6:177-185.
23. Johnson L, ed. Essential Medical Physiology, 2nd ed. Philadelphia: Lippincott-Raven, 1998.
24. Karol LA, Concha MC, Johnston CE 2d. Gait analysis and muscle strength in children with surgically treated clubfeet. J Pediatr Orthop. 1997;6:790-795.
25. Karol LA, Mayberry S, O'Brien O, et al. Gait in patients with clubfeet: a comparison of physical therapy versus surgical release. Pediatric Orthopaedic Society of North America 2003 Annual Meeting, Amelia Island Florida, May 2-4, 2003.
26. Klein AW. Complications and adverse reactions with the use of botulinum toxin. Semin Cutan Med Surg. 2001;20:109-120.
27. Koman LA, Mooney JF, Smith B, et al. Management of cerebral palsy with botulinum A toxin: preliminary investigation. J Pediatr Orthop. 1993;13:489-495.
28. Kuo KN, Hennigan SP, Hastings ME. Long term results of clubfoot release, outcome study and gait analysis. Pediatric Orthopaedic Society of North America 2003 Annual Meeting, Amelia Island, Florida, May 2-4, 2003.
29. Laaveg SJ, Ponseti IV. Long-term results of treatment of congenital clubfoot. J Bone Joint Surg [Am]. 1980;62:23-31.
30. Lehman WB, Scher DM, Feldman DS, et al. Method of evaluating the effectiveness of the Iowa (Ponseti) clubfoot technique. International Society of Orthopaedic Surgery and Traumatology 3rd International Clubfoot Congress, San Diego, California, August 2002.
31. McKay DW. New concept of and approach to clubfoot treatment: section 11. Correction of the clubfoot. J Pediatr Orthop. 1983;3:10-21.
32. McNecr KW, Tucker MG, Spencer RF. Management of essential infantile esotropia with botulinum toxin A: review and recommendations. J Pediatr Ophthalmol Strabismus. 2000;37:63-67.
33. Miller JH, Bernstein SM. The roentogenographic appearance of the corrected clubfoot. Foot Ankle. 1986;6:177-183.
34. Mooney JF, Koman LA, Smith BP. Pharmacologic management of spasticity in cerebral palsy. J Pediatr Orthop. 2003;23:679-686.
35. rd International Clubfoot Congress, San Diego, California, August 2002.
36. Morrissy RT, Weinstein SL, eds. Lovell and Winter's Pediatric Orthopaedics. 2nd ed. Philadelphia: Lippincott-Raven, 1996.
37. Otis JC, Bohne WH. Gait analysis in surgically treated clubfoot. J Pediatr Orthop. 1986;6:162-164.
38. Pirani S, Outerbridge H, Moran M, Sawatsky BJ. A method of evaluating the virgin clubfoot with substantial interobserver reliability. Pediatric Orthopaedic Society of North America 1995 Annual Meeting, Miami, Florida, May 1995.
39. Pirani S. Ponseti treatment of the congenital clubfoot: the New Westminster experience. International Society of Orthopaedic Surgery and Traumatology 3rd International Clubfoot Congress, San Diego, California, August 2002.
40. Ponseti IV. Treatment of congenital clubfoot. J Bone Joint Surg [Am]. 1992;74:448-454.
41. Ponseti IV. Congenital Clubfoot: Fundamentals of Treatment. New York: Oxford University Press, 1996.
42. Ponseti IV. Common errors in the treatment of congenital clubfoot. Int Orthop. 1997;21:137-141.
43. Ponseti IV. Clubfoot management. J Pediatr Orthop. 2000;20:699-700.
44. Richards BS, Wilson H. Non-operative clubfoot treatment using physical therapy. International Society of Orthopaedic Surgery and Traumatology 3rd International Clubfoot Congress, San Diego, California, August 2002.
45. Roye DP, Roye BD. Idiopathic congenital talipes equinovarus. J Am Acad Orthop Surg. 2002;10:239-248.
46. Schlafly B, Butler JE, Siff SJ. The appearance of the tarsal navicular after posteromedial release for clubfoot. Foot Ankle. 1985;5: 222-237.
47. Scott AB. Botulinum A injection of eye muscles to correct strabismus. Trans Am Ophthalmol Soc. 1981;79:734-770.
48. Turco VJ. Surgical correction of the resistant clubfoot: one-stage posteromedial release with internal fixation. A preliminary report. J Bone Joint Surg [Am]. 1971;53:477-497.
49. Widhe T, Berggren I. Gait analysis and dynamic foot pressure in the assessment of the treated clubfoot. Foot Ankle Int. 1994;15: 186-190.